Checchi Capital Advisers, LLC Prothena Corp Public LTD CO Transaction History

Checchi Capital Advisers, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2018 May 01, 2018	SELL	$27.95 - $45.04 $266,307 - $429,141	-9,528 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$35.44 - $63.76 $70,880 - $127,520	-2,000 Reduced 17.35%	9,528 $357,000
Q3 2017 Nov 02, 2017	BUY	$53.83 - $67.75 $620,552 - $781,022	11,528	11,528 $747,000

184

42.7M

162K

102K

Ticker PRTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,922,800
Market Cap $714M
Description
Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...

Get notified when there are updates to the investment portfolio of Checchi Capital Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Checchi Capital Advisers, LLC with notifications on news.